Price history & market evidence
Price observations belong to this edition. Guide estimates, catalog references and completed sales are separate kinds of evidence.
| Grade | Amount | Evidence | Recorded |
|---|---|---|---|
| 10.0 | $100.00 | PANEL_PROFITS · grade_10_0_valueguide | Date not recorded |
| 4.0 | $5.82 | PANEL_PROFITS · grade_4_0_valueguide | Date not recorded |
| 6.0 | $13.71 | PANEL_PROFITS · grade_6_0_valueguide | Date not recorded |
| 8.0 | $20.19 | PANEL_PROFITS · grade_8_0_valueguide | Date not recorded |
| 9.2 | $28.62 | PANEL_PROFITS · grade_9_2_valueguide | Date not recorded |
| 9.6 | $85.00 | PANEL_PROFITS · grade_9_6_valueguide | Date not recorded |
| 9.8 | $77.13 | PANEL_PROFITS · grade_9_8_valueguide | Date not recorded |
| RAW | $6.81 | PANEL_PROFITS · ungraded_valueguide | Date not recorded |
Reading this edition’s market
Compare the same cover, printing and grade before setting a bid. A raw guide or a higher-grade price does not establish a slab’s value. Include selling fees, shipping and the depth of completed-sale evidence when assessing an exit price.
The table includes 8 guide observations and 0 catalog references. These are reference values, not guaranteed sale proceeds.
Graded population
No unambiguous year-and-edition population match is attached to this record.
Sins of the Future
| Appearing1 = **Featured Characters:** * Nightwatch) **Supporting Characters:** * Venom)||Venom: Nights of Vengeance Vol 1 1 * Drake Trench) **Antagonists:** * Morelle Pharmaceuticals) - Silent Shadows%23Silent_Shadows) * Cardiaxe) **Other Characters:** * Ashley Croix) * Damon Morelle) * Killian Fox) **Realities:** * Earth-616 **Locations:** * San Francisco ** Morelle Pharmaceuticals research facility ** Haight-Ashbury * New York City ** Wirtham Institute
**Items:** * Venom Symbiote_(Earth-616))
| Notes = | Trivia = | Recommended = | Links =
Creative credits
Writers: Terry Kavanagh
Interior art: Mark Tenney
Color: Lia Pelosi
Source records & attribution
Panel Profits keeps each source identity attached to its edition record.
PANEL PROFITS: 3459134